Rimactane and disseminated intravascular coagulation Patient Reports February 12, 2012

Rimactane Side Effects Report #5259057-0
Rimactane side effect was reported by a Physician from JAPAN on Feb 21, 2007. Female patient, 75 years of age, weighting 72.75 lb, was diagnosed with mycobacterial infection and was treated with Rimactane. After drug was administered, patient experienced the following side effects: blood glucose decreased, blood pressure decreased, cardio-respiratory arrest, condition aggravated, disseminated intravascular coagulation, haemolytic anaemia, hepatitis fulminant, loss of consciousness, melaena. Rimactane dosage: 450 MG, ORAL. During the same period patient was treated with ETHAMBUTOL HYDROCHLORIDE, CLARITHROMYCIN, MUCODYNE, GLORIAMIN, PURSENNID, KAMAG G, JUZENTAIHOTO, UNASYN. Patient was hospitalized. Patient died on 10/09/2006.

Rimactane Side Effects Report #5148158-3
Rimactane side effect was reported by a Physician from JAPAN on Oct 26, 2006. Female patient, 75 years of age, weighting 72.75 lb, was diagnosed with mycobacterial infection and was treated with Rimactane. After drug was administered, patient experienced the following side effects: acid fast bacilli infection, angina unstable, blood glucose decreased, blood pressure decreased, cardio-respiratory arrest, condition aggravated, continuous haemodiafiltration, disseminated intravascular coagulation, dyspnoea. Rimactane dosage: 450 MG, ORAL. During the same period patient was treated with ETHAMBUTOL, CLARITHROMYCIN, MUCODYNE, GLORIAMIN, PURSENNID, KAMAG G, JUZENTAIHOTO, UNASYN. Patient was hospitalized. Patient died on 10/09/2006.